Xeris Biopharma Holdings, Inc.XERSNASDAQ
Loading
Revenue (LTM)
$292M
+43.7% YoY
Net Income (LTM)
$554000
+101.0% YoY
Free Cash Flow
$28M
Revenue CAGR (5Y)
+70.2%
Marginsimproving
|FCFTurned positive
|Now profitable
Income Statement
| Metric | Dec 21 | Dec 22 | Dec 23 |
|---|---|---|---|
| Revenue | 50 | 110 | 164 |
| Gross Profit | 36 | 88 | 135 |
| Operating Income | -115 | -82 | -44 |
| Net Income | -123 | -95 | -62 |
| EBITDA | -114 | -69 | -24 |
| EPS Diluted | -1.55 | -0.70 | -0.45 |
Balance Sheet
| Metric | Dec 21 | Dec 22 | Dec 23 |
|---|---|---|---|
| Cash & Equivalents | 67 | 122 | 67 |
| Total Current Assets | 143 | 187 | 156 |
| Total Assets | 304 | 345 | 323 |
| Total Current Liabilities | 79 | 74 | 95 |
| Total Liabilities | 209 | 299 | 329 |
| Total Equity | 95 | 45 | -7 |
| Total Debt | 88 | 198 | 229 |
| Net Debt | 21 | 76 | 162 |
Cash Flow Statement
| Metric | Dec 21 | Dec 22 | Dec 23 |
|---|---|---|---|
| Operating Cash Flow | -96 | -103 | -47 |
| Capital Expenditure | -1 | -1 | -2 |
| Free Cash Flow | -103 | -103 | -49 |
| Stock-Based Comp | 11 | 12 | 11 |
| Net Change in Cash | 59 | 59 | -55 |
Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down